ModuleTitle@CompanyName@Symbol@Address@Phone@Industry@Sector@Region@CompanyDescription@KeyExecutives
Company Description@Regeneron Pharmaceuticals, Inc.@REGN@777 OLD SAW MILL RIVER ROAD, TARRYTOWN, New York, 10591, United States of America@9148477000@Major Pharmaceuticals@Health Care@North America@"This Annual Report on Form 10-K contains forward-looking statements that involve
risks and uncertainties relating to future events and the future performance of
Regeneron Pharmaceuticals, Inc. (where applicable, together with its
subsidiaries, ""Regeneron,"" ""Company,"" ""we,"" ""us,"" and ""our""), and actual events
or results may differ materially from these forward-looking statements. Words
such as ""anticipate,"" ""expect,"" ""intend,"" ""plan,"" ""believe,"" ""seek,"" ""estimate,""
variations of such words, and similar expressions are intended to identify such
forward-looking statements, although not all forward-looking statements contain
these identifying words.&nbsp;&nbsp;... <a href=""http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f02%2f07%2f0001532176-20-000008.html#FIS_BUSINESS"" target=""_blank"">More</a> ...&nbsp;&nbsp;
"@[('George Damis Yancopoulos', 'Co-President, Director & Chief Scientific Officer'), ('Leonard S. Schleifer', 'Co-President, Chief Executive Officer & Director'), ('Neil Stahl', 'Executive VP-Research & Development'), ('Robert E. Landry', 'Chief Financial Officer & Executive VP-Finance')]
